Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis.
Zivadinov R, Bergsland N, Jakimovski D, Weinstock-Guttman B, Lorefice L, Schoonheim MM, Morrow SA, Ann Picone M, Pardo G, Zarif M, Gudesblatt M, Nicholas JA, Smith A, Hunter S, Newman S, AbdelRazek MA, Hoti I, Riolo J, Silva D, Fuchs TA, Dwyer MG, Hb Benedict R. Zivadinov R, et al. Among authors: gudesblatt m. Neuroimage Clin. 2024;42:103609. doi: 10.1016/j.nicl.2024.103609. Epub 2024 Apr 27. Neuroimage Clin. 2024. PMID: 38718640 Free PMC article.
Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?
Bogaardt H, Golan D, Barrera MA, Attrill S, Kaczmarek O, Zarif M, Bumstead B, Buhse M, Wilken J, Doniger GM, Hancock LM, Penner IK, Halper J, Morrow SA, Covey TJ, Gudesblatt M. Bogaardt H, et al. Among authors: gudesblatt m. Mult Scler Relat Disord. 2023 May;73:104630. doi: 10.1016/j.msard.2023.104630. Epub 2023 Mar 21. Mult Scler Relat Disord. 2023. PMID: 36965219 Free article.
Multiple sclerosis and quality of life: The role of cognitive impairment on quality of life in people with multiple sclerosis.
Bergmann C, Becker S, Watts A, Sullivan C, Wilken J, Golan D, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Covey TJ, Doniger GM, Penner IK, Hancock LM, Bogaardt H, Barrera MA, Morrow S, Gudesblatt M. Bergmann C, et al. Among authors: gudesblatt m. Mult Scler Relat Disord. 2023 Nov;79:104966. doi: 10.1016/j.msard.2023.104966. Epub 2023 Sep 3. Mult Scler Relat Disord. 2023. PMID: 37690436
Multiple Sclerosis, Fatigue, Expanded Disability Status Scale: A Cross-Sectional Exploration of Sleep Efficiency and Quantitative Sleep Parameters.
Queisi M, Attarian H, Cipriani VP, Azzi S, Kaczmarek O, Bumstead B, Buhse M, Zarif M, Golan D, Wilken J, Covey T, Gudesblatt M. Queisi M, et al. Among authors: gudesblatt m. Int J MS Care. 2024 Mar-Apr;26(2):57-60. doi: 10.7224/1537-2073.2022-118. Epub 2024 Mar 11. Int J MS Care. 2024. PMID: 38482517 Free PMC article.
Exploring the relationship between manual dexterity and cognition in people with multiple sclerosis: 9-hole peg and multiple cognitive functions.
Abraham R, Waldman-Levi A, Barrera MA, Bogaardt H, Golan D, Bergmann C, Sullivan C, Wilken J, Zarif M, Bumstead B, Buhse M, Covey TJ, Doniger GM, Penner IK, Hancock LM, Morrow SA, Giroux E, Gudesblatt M. Abraham R, et al. Among authors: gudesblatt m. Mult Scler Relat Disord. 2024 Aug;88:105696. doi: 10.1016/j.msard.2024.105696. Epub 2024 May 27. Mult Scler Relat Disord. 2024. PMID: 38850796
De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel Fumarate.
Gudesblatt M, Bumstead B, Buhse M, Zarif M, Morrow SA, Nicholas JA, Hancock LM, Wilken J, Weller J, Scott N, Gocke A, Lewin JB, Kaczmarek O, Mendoza JP, Golan D. Gudesblatt M, et al. Adv Ther. 2024 Aug;41(8):3059-3075. doi: 10.1007/s12325-024-02902-0. Epub 2024 Jun 11. Adv Ther. 2024. PMID: 38861218 Free PMC article.
Polysomnography parameters in a large cohort of people with multiple sclerosis.
Queisi M, Cipriani V, Golan D, El Ghorayeb C, Zarif M, Bumstead B, Buhse M, Weller J, Mattoo A, Gudesblatt M, Attarian H. Queisi M, et al. Among authors: gudesblatt m. Sleep Med. 2024 Sep;121:236-240. doi: 10.1016/j.sleep.2024.07.009. Epub 2024 Jul 10. Sleep Med. 2024. PMID: 39018796
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study.
Singer BA, Wray S, Gudesblatt M, Bumstead B, Ziemssen T, Bonnell A, Scaramozza M, Levin S, Shanmugasundaram M, Chen H, Mendoza JP, Lewin JB, Shankar SL. Singer BA, et al. Among authors: gudesblatt m. Neurol Ther. 2024 Aug;13(4):1273-1285. doi: 10.1007/s40120-024-00637-2. Epub 2024 Jun 27. Neurol Ther. 2024. PMID: 38935202 Free PMC article.
84 results